1. Paper › Research › Not peer-reviewed
2. Published

   Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?

   Hughes, D., Hughes, D. A. & Pirmohamed, M., 1 Nov 2003.

   Research output: Contribution to conference › Paper

3. Published

   Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?

   Hughes, D. & Hughes, D. A., 1 Jun 2003.

   Research output: Contribution to conference › Paper

4. Published

   Abacavir hypersensitivity: Is pre-prescription genotyping cost-effective?

   Hughes, D. & Hughes, D. A., 1 May 2003.

   Research output: Contribution to conference › Paper

5. Published

   Accurate and practical dosing of African populations using a height, weight and age model designed for lapdap

   Hughes, D., Hughes, D. A. & Bagust, A., 1 Nov 2002.

   Research output: Contribution to conference › Paper

6. Published

   Adherence with HAART: pharmacoeconomic considerations

   Hughes, D. & Hughes, D. A., 1 Jun 2007.

   Research output: Contribution to conference › Paper

7. Published

   Adverse drug reactions in economic evaluations

   Hughes, D. & Hughes, D. A., 1 Jul 2007.

   Research output: Contribution to conference › Paper

8. Published

   Adverse drug reactions in economic evaluations

   Hughes, D. & Hughes, D. A., 1 Mar 2007.

   Research output: Contribution to conference › Paper

9. Published

   Adverse drug reactions: analysis by regulatory authorities and by economists

   Hughes, D. & Hughes, D. A., 1 Apr 2007.

   Research output: Contribution to conference › Paper

10. Published

    Assessing the association between compliance and therapeutic failure for antiretroviral drugs in HIV positive patients

    Hughes, D. & Hughes, D. A., 1 May 2007.

    Research output: Contribution to conference › Paper

11. Published

    Assessing the association between compliance and therapeutic failure for antiretroviral drugs in HIV positive patients

    Hughes, D., 1 Mar 2007.

    Research output: Contribution to conference › Paper